ARTICLE | Clinical News

DCVax-Brain: Phase I data

June 6, 2005 7:00 AM UTC

Data from a Phase I trial in 7 newly diagnosed GBM and 5 recurrent GBM patients showed that 3 injections of DCVax-Brain over 6 weeks increased survival times and time to progression times. In the pati...